Bharat Biotech inks pact to supply Covaxin to Brazil
Tuesday, 12 January 2021 () Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian market. The Covaxin doses will be manufactured in India and exported to Brazil where they will be distributed by Precisa.
Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants. Panda added that India has taken a smart vaccination approach. “Covaxin presents to the immune system a wide array of antigens,” said...
India's government has cleared commercial exports of Covid-19 vaccines, with the first consignments to be shipped to Brazil and Morocco on Friday, the Indian.. IndiaTimes
Brazil and Morocco will be the first two countries that are getting the commercial contracted supplies of 20 lakh doses each, of COVID-19 vaccines. DNA
Brazilian military flew medical personnel and 1,000 doses of a Chinese vaccine deep into the Amazon rainforest on Tuesday to start inoculating indigenous people against the coronavirus. Gloria Tso reports.
Brazilian military flew medical personnel and 1,000 doses of a Chinese vaccine deep into the Amazon rainforest on Tuesday to start inoculating indigenous people against the coronavirus. Gloria Tso reports.
An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against.. IndiaTimes
Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.
Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. Out of the.. IndiaTimes
Union Health minister Dr. Harsh Vardhan reiterated the two vaccines which have been granted approval for use in India are safe and effective. He added that some people are playing politics over the issue resulting in vaccine hesitancy among a section of the people. Harsh Vardhan said that the vaccines will be the last nail in the coffin of Covid. He also said that mild fever, pain and swelling are common after vaccination and added that very few people have shown these side-effects too. Questions have been raised about the safety of Covaxin which has not yet published any data from phase three clinical trials. Additionally, the government has also said that people will not get to choose a vaccine in the first phase. Watch the full video for all the details.
Credit: HT Digital Content Duration: 03:11Published
Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities. He said, "There are two vaccines. One of the two vaccines is given emergency use authorization under clinical trial mode. In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."
With vaccination programmes being rolled out across the continent, health authorities are keen to see them adopted by all communities.
But against them are anti-vaxx campaigns.
Credit: euronews (in English) Duration: 01:36Published
During a White House press briefing, Dr. Anthony Fauci told reporters that he feels liberated to speak freely and honestly about the coronavirus pandemic and the science behind it under the Biden administration.
Covaxin maker Bharat Biotech has issued a fact sheet which details which categories of people should not be administered with the vaccine or which groups should take the vaccine with caution. Watch the..
On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made..
Credit: HT Digital Content Duration: 08:15Published
Bharat Biotech has said that it will pay recipients of the vaccine Covaxin compensation if beneficiaries face any adverse effects after taking it while the vaccine remains in clinical trial mode. Watch..
Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous... IndiaTimes Also reported by •DNA •Hindu
Beneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally... IndiaTimes